Trigger Factors in Transfusion Medicine: Proceedings of the Twentieth International Symposium on Blood Transfusion, Groningen 1995, organized by the Red Cross Blood Bank Noord-Nederland / Edition 1by Cees Smit Sibinga
Pub. Date: 10/31/1996
Publisher: Springer US
Transfusion medicine is an excellent way for the healthy community to help the sick. However, service providers and patients have much to gain from the establishment of guidelines concerning when and how it is used. An important first step would be to introduce informed consent for transfusion recipients. Discussions with blood banks and assessment of clinical… See more details below
Transfusion medicine is an excellent way for the healthy community to help the sick. However, service providers and patients have much to gain from the establishment of guidelines concerning when and how it is used. An important first step would be to introduce informed consent for transfusion recipients. Discussions with blood banks and assessment of clinical demand would also be necessary, taking into account the needs of patients and physicians, and the availability of products. Unfortunately, the efficacy and safety of transfusion products can be difficult to ascertain. Furthermore, although major advances have been made in safety, the risks of giving and receiving blood are still seen as high.
It is vital to learn what underlies that perception and how to counter it. The policies and prools used to establish surgical criteria for blood transfusions should be explored. Finally, clinical audits can help evaluate the risk:benefit ratio of transfusion; they may be carried out by hospital transfusion committees but are likely to be more successful with the support of national and international legislative and regulatory bodies. The implementation of appropriate initiatives now will improve the outlook for the future of transfusion medicine, perhaps with ex-vivo expanded haemopoietic cell therapy as the next milestone.
All these key points and controversies are explored in this book, which paints a broad picture of the current status and future trends in transfusion medicine.
- Springer US
- Publication date:
- Developments in Hematology and Immunology (closed) Series, #31
- Edition description:
- Product dimensions:
- 9.21(w) x 6.14(h) x 0.69(d)
Table of Contents
Foreword. I: Demand and Supply. Customer-Oriented Quality Systems in Transfusion; D.E. Nevalainen. Communication Mechanisms Between the Bedside and the Blood Bank; A.W.M. Koopman-Van Gemert. Informed Consent for Transfusion Recipients: How Much is Enough? P.V. Holland. Factors that Influence the Demand for Transfusion; D.B.L. McClelland. The Process of Clinical Decision Making in Blood Transfusion; L.T. Goodnough. II: Product Qualities and Characteristics. Factors Defining the Clinical Needs for Supportive Haemotherapy; J.Th.M. de Wolf. Factors Effecting the Clinical Efficacy of Blood Transfusion; W.G. Murphy. The Clinical Relevance and Biological Effects of Leukocytes Present in Cellular Blood Components; M. Blajchman. Platelets: What Qualities and Characteristics Do Justify the Need for Transfusion? S. Murphy. The Clinical Relevance of Clotting Factor Characteristics; C.A. Ludlam. Discussion. III: Transfusion Policies and Clinical Practice. Fears, Facts and Formulas About Blood Transfusion: On the Perception, Acceptance and Communication of Risks; C.A.J. Vlek. Surgical Criteria for Blood Transfusion: How Far Should We Go? H.J. ten Duis. Transfusion Policies and Clinical Practice in a Tertiary Academic Medical Centre: The Role of Prools and Documentation; M. Petrides, E.L. Snyder. Choice of Transfusing Single Donor Apheresis vs Random Pooled Platelets - Its Costs; A. Westerterp-Maas. Ethical Aspects of the Transfusion of Blood; C.R. MacPherson. What Triggers the Initiative of Developments in Transfusion Medicine: Advances in Ex Vivo Haematopoietic Cell Therapy and Next Generation Transfusion Products; D.E. van Epps. Discussion. IV. Evaluation and Feed-Back of Transfusion Policies. Evaluation of Bedside Transfusion Practice: Benefits vs Risks; R.S. Eisenstaedt. The Clinical Consultative Role of the Blood Bank in Transfusion Medicine; C.Th. Smit Sibinga. Audits in Transfusion Medicine: A Trigger Mechanism to Optimise Clinical Practice; Ch.H. Wallas. Legislative and Regulative Impact on Transfusion Medicine Practices; K. Sazama. Discussion. Index.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >